Skip to main content
. 2016 Jan 30;7(8):8743–8755. doi: 10.18632/oncotarget.7087

Figure 2. Kaplan-Meier estimates of overall survival and time to progression of the prognostic groups identified by the signature.

Figure 2

(A) Overall survival curves for the GC35 dataset. (B) Overall survival curves for the GC123 dataset. (C) Time to progression curves for the GC123 dataset. (D) Overall survival curves of the 130 gastric cancer patients treated with surgery alone.